When it was announced in 2023 that the world’s first Crispr-based gene-editing therapy had been approved in the UK there was ...

AI‑driven protein design creates potent anti‑CRISPR inhibitors that block Cas13 activity, offering a new potential tool for safer, more controlled gene editing.

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

The rapid evolutionary dynamics of RNA viruses, driven by high mutation rates and the consequent formation of complex ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

Diagnostic Enzymes Research Report 2026 - Global $8.72 Bn Market Trends, Opportunities, And Forecasts To 2031. The Global Diagnostic Enzymes Market is driven by rising chronic disease prevalence ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

We came across a bullish thesis on C4 Therapeutics, Inc. on Ridire Research’s Substack. In this article, we will summarize ...

FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.